Universita' Degli Studi Di Modena E Reggio Emilia
- Address
- lock Available on a paid plan
Cardiovascular and Metabolic Research
At Universita' Degli Studi Di Modena E Reggio Emilia, clinical trials in cardiovascular diseases and metabolic disorders are examining ways to improve long-term control of conditions such as familial hypercholesterolemia, uncontrolled hypertension, and HIV with obesity. These studies focus on testing new treatment approaches and assessing their safety and effectiveness in everyday care.
- Long-term management of familial hypercholesterolemia through therapies designed to support safer cholesterol control
- Evaluation of a new option for resistant hypertension to help improve blood pressure reduction
- Research on HIV and obesity aimed at supporting weight loss and metabolic health
This research reflects a strong interest in chronic disease management, with an emphasis on better treatment durability, symptom control, and overall patient outcomes.
Oncology and Hematology Studies
The site is active in neoplasms and hemic and lymphatic diseases, with trials exploring treatments for advanced cancer, metastatic breast cancer, chronic lymphocytic leukemia, and small lymphocytic lymphoma. The main goal is to evaluate whether new cancer therapies can improve disease control and support safer, more effective care.
- Studies in advanced or metastatic non-small-cell lung cancer examining new approaches for difficult-to-treat EGFR mutation subtypes
- Research in metastatic HER2-positive breast cancer comparing treatment options to strengthen anti-tumor response
- Trials in chronic lymphocytic leukemia and small lymphocytic lymphoma focused on improving first-line therapy outcomes
- Safety-focused studies of immune-based cancer treatment for patients with different types of advanced cancer
These oncology programs combine treatment comparison and safety assessment to advance care for patients with complex and often aggressive cancers.
Dermatology and Skin Health Trials
Clinical research in skin and connective tissue diseases at this site includes studies on acne vulgaris and actinic keratosis. The trials are designed to test new topical therapies, monitor long-term safety, and reduce the risk of more serious skin changes.
- Treatment research for acne vulgaris focused on improving skin clearance and tolerability
- Prevention-oriented work in actinic keratosis assessing protection against progression to squamous cell carcinoma
- Comparative studies of topical options to support better everyday management of chronic skin conditions
The dermatology portfolio centers on practical, patient-friendly therapies that may improve both symptom control and long-term skin safety.
Hormonal and Symptom Relief Research
Trials in hormonal diseases are addressing moderate to severe vasomotor symptoms in women receiving treatment for hormone receptor-positive breast cancer. The research aims to find better ways to ease hot flashes and improve quality of life during cancer care.
- Symptom-focused research on vasomotor symptoms linked to endocrine therapy
- Evaluation of non-hormonal treatment strategies to reduce hot flash frequency and severity
- Supportive care studies aimed at improving comfort during long-term breast cancer treatment
This area highlights the site’s interest in supportive oncology, where controlling treatment-related symptoms is an important part of overall care.
Blood Disorders and Rare Disease Investigations
The research portfolio also includes hemic and lymphatic diseases such as sickle cell disease and related anemia. These studies are designed to assess whether new therapies can improve blood health, reduce symptoms, and lower the burden of disease.
- Studies in sickle cell disease evaluating treatment effects on anemia and pain-related complications
- Research aimed at improving day-to-day stability and quality of life for people living with chronic blood disorders
By focusing on both symptom relief and broader disease control, this work supports advances in care for patients with complex hematologic conditions.
Viral Disease and Immune-Related Research
In the area of virus diseases, the site is involved in studies that connect infectious disease with broader health challenges, including HIV and obesity. The purpose of this research is to explore treatment strategies that may improve overall health outcomes in people living with long-term viral infection.
- Clinical research focused on HIV and associated metabolic complications
- Studies designed to support healthier weight management and better long-term wellbeing
This work shows how infectious disease research at the site overlaps with metabolic care, reflecting a broader view of patient health.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 9 therapeutic areas and 15 of 71 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 67 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 8 by active trials.
- 1Novartis Pharma AG1active
lock +7 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Novartis Pharma AG2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 566 other sites in Italy
Therapeutic Area Benchmark — Italy
Select a therapeutic area to compare against other sites in Italy.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Italy
Market Share
Country: Italy
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Universita' Degli Studi Di Modena E Reggio Emilia
lock Showing 1 of 18 trials — the rest is available on a paid plan.
IMP list
lock Showing 1 of 71 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Rituximab | 3 | Unknown | 2018-05-28 | 2024-02-01 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.